A carregar...
Effect of bortezomib on human neuroblastoma: analysis of molecular mechanisms involved in cytotoxicity
BACKGROUND: Bortezomib, a specific and selective inhibitor of the 26S proteasome with antitumor activity against a wide range of malignancies, has been approved for the treatment of relapsed or refractory multiple myeloma and other cancers. Recently, bortezomib has been identified as an effective in...
Na minha lista:
| Main Authors: | , , , , , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
BioMed Central
2008
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2442611/ https://ncbi.nlm.nih.gov/pubmed/18534018 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1476-4598-7-50 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|